Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis.

Behera AK, Hildebrand E, Scagliotti J, Steere AC, Hu LT.

Infect Immun. 2005 Jan;73(1):126-34.

2.

Host metalloproteinases in Lyme arthritis.

Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, Pratta MA, Grodzinsky AJ, Loening A, Perides G.

Arthritis Rheum. 2001 Jun;44(6):1401-10.

3.

Role of aggrecanase 1 in Lyme arthritis.

Behera AK, Hildebrand E, Szafranski J, Hung HH, Grodzinsky AJ, Lafyatis R, Koch AE, Kalish R, Perides G, Steere AC, Hu LT.

Arthritis Rheum. 2006 Oct;54(10):3319-29.

4.

Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment.

Lin B, Kidder JM, Noring R, Steere AC, Klempner MS, Hu LT.

J Infect Dis. 2001 Jul 15;184(2):174-80. Epub 2001 Jun 25.

PMID:
11424014
6.

Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.

Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT.

Infect Immun. 2009 Jul;77(7):2643-9. doi: 10.1128/IAI.00214-09. Epub 2009 Apr 13.

7.

Temporospatial expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mouse antigen-induced arthritis.

Joronen K, Kähäri VM, Vuorio E.

Histochem Cell Biol. 2005 Dec;124(6):535-45. Epub 2005 Aug 27.

PMID:
16133125
8.
9.

Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.

Ma Y, Seiler KP, Eichwald EJ, Weis JH, Teuscher C, Weis JJ.

Infect Immun. 1998 Jan;66(1):161-8.

10.

5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.

Blaho VA, Zhang Y, Hughes-Hanks JM, Brown CR.

J Immunol. 2011 Mar 1;186(5):3076-84. doi: 10.4049/jimmunol.1003473. Epub 2011 Jan 26.

13.

Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3.

Oosting M, Buffen K, Malireddi SR, Sturm P, Verschueren I, Koenders MI, van de Veerdonk FL, van der Meer JW, Netea MG, Kanneganti TD, Joosten LA.

Arthritis Res Ther. 2012 Nov 13;14(6):R247. doi: 10.1186/ar4090.

14.

Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Seiler KP, Vavrin Z, Eichwald E, Hibbs JB Jr, Weis JJ.

Infect Immun. 1995 Oct;63(10):3886-95.

16.

Differential expression of matrix metalloproteinases and cyclooxygenases in synovial cells exposed to Borrelia burgdorferi.

Singh SK, Morbach H, Nanki T, Faber C, Baar V, Girschick HJ.

Inflamm Res. 2004 Dec;53(12):689-96.

PMID:
15654517
17.

Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.

Heard BJ, Martin L, Rattner JB, Frank CB, Hart DA, Krawetz R.

BMC Musculoskelet Disord. 2012 Jul 23;13:126. doi: 10.1186/1471-2474-13-126.

18.

The DBA/1 strain is a novel mouse model for experimental Borrelia burgdorferi infection.

Campfield BT, Nolder CL, Davis A, Hirsch R, Nowalk AJ.

Clin Vaccine Immunol. 2012 Oct;19(10):1567-73. Epub 2012 Aug 1.

19.

Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi.

Potter MR, Rittling SR, Denhardt DT, Roper RJ, Weis JH, Teuscher C, Weis JJ.

Infect Immun. 2002 Mar;70(3):1372-81.

20.

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.

Arthritis Rheum. 2005 Oct;52(10):3239-47.

Supplemental Content

Support Center